Currently, out of the existing stock ratings of Robbie Marcus - 147 which are a Buy (73.87%), 41 which are a Hold (20.6%), 11 which are a Sell (5.53%)

Robbie Marcus

Work Performance Price Targets & Ratings Chart

Analyst Robbie Marcus works at JPMORGAN and is covering the Healthcare sector with 360 price targets and ratings displayed on 32 stocks.

Robbie Marcus's average stock forecast success ratio is 60.36% with an average time for price targets to be met of 157.84 days.

Most recent stock forecast was given on COO, The Cooper Companies at 29-Nov-2023.

Wall Street Analyst Robbie Marcus

Analyst best performing recommendations are on BLCO.
The best stock recommendation documented was for INGN (INOGEN) at 5/8/2019. The price target of $72 was fulfilled within 1 day with a profit of $4.21 (6.21%) receiving and performance score of 62.1.

Average potential price target upside

of $44.49 (19.92%) on PEN (PENUMBRA).
of $32.64 (16.11%) on SYK (STRYKER).
of $31.64 (14.38%) on BDX (BECTON, DICKINSON AND COMPANY).

AFIB Acutus Medical DXCM DexCom GKOS Glaukos INGN Inogen IRTC iRhythm Technologies MDT Medtronic plc SDC SmileDirectClub IART Integra LifeSciences Holdings PEN Penumbra EAR RXST SYK Stryker TMCI Treace Medical Concepts ABT Abbott Laboratories ATRC AtriCure BAX Baxter International BDX Becton, Dickinson and Company BVS Bioventus EW Edwards Lifesciences IRT UTRS BLCO ZBH Zimmer Biomet Holdings BSX Boston Scientific COO The Cooper Companies INSP Inspire Medical Systems ISRG Intuitive Surgical NVRO Nevro PODD Insulet SILK Silk Road Medical XENT CNMD CONMED

Show more stocks

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

William Plovanic (CANACCORD)